Outcomes of the Nanoscopic Partial Meniscectomy Versus Standard Arthroscopic Partial Meniscectomy
Launched by MARSHALL UNIVERSITY · Nov 12, 2022
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different ways to treat meniscus tears, which are injuries to the cartilage in the knee. The researchers want to compare the traditional method of surgery, called standard arthroscopy, with a newer technique that uses a smaller tool called a Nanoscope. They believe that patients who have the nanoscopic surgery will experience less pain and be able to return to their normal activities more quickly than those who have the standard surgery.
To join this study, participants need to be diagnosed with a meniscus tear confirmed by an MRI and have enough space in the knee joint for the surgery. The trial is open to people of all genders aged between 18 and 60, but it excludes those who have had previous knee surgeries or are receiving workers' compensation. If you decide to participate, you can expect to receive either the traditional or the new surgical method and will be monitored for how well your knee heals and how quickly you can get back to your daily life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • MRI positive for meniscus tear
- • More than 3mm of joint space on PA flexion weightbearing x rays
- • Primary arthroscopy
- Exclusion Criteria:
- • Workers compensation
- • Older than 60 years of age
- • Revision surgeries
About Marshall University
Marshall University, a distinguished institution located in Huntington, West Virginia, is dedicated to advancing healthcare through innovative research and clinical trials. With a robust focus on medicine, health sciences, and community engagement, the university collaborates with various stakeholders to conduct research that addresses critical health challenges. Marshall University leverages its state-of-the-art facilities and a team of experienced researchers to facilitate rigorous clinical trials, aiming to improve patient outcomes and contribute to the scientific community. Through its commitment to ethical practices and regulatory compliance, Marshall University strives to enhance the quality of life for individuals while fostering educational opportunities for future healthcare professionals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Washington, District Of Columbia, United States
Scott Depot, West Virginia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials